Your search history is turned on.
Date: February 10, 2017 Jurisdictions: Alberta, British Columbia, Ontario
CompanyDocuments Number: C1102183 CERTIFICATE OF CONTINUATION BUSINESS CORPORATIONS ACT I Hereby Certify that Avagenesis Corp. , has continued into British Columbia from the Jurisdiction of ALBERTA, under the Business Corporations Act, with the name LIBERTY BIOPHARMA INC. on December 30, 2016 at 08:53 AM Pacific Time. Issued under my hand...
Amended Notice of Change in Corporate Structure NOTICE OF CHANGE IN CORPORATE STRUCTURE National Instrument 51-102 Section 4.9 This notice is provided pursuant to the requirements of Section 4.9 of National Instrument 51-102 Continuous Disclosure Obligations (NI 51-102). Item 1 Names of the parties to the transaction ...
Date: January 24, 2017 Jurisdictions: Alberta, British Columbia, Ontario
20161230 Liberty Biopharma Amalgamation Certificate Number: BC1102311 CERTIFICATE OF AMALGAMATION BUSINESS CORPORATIONS ACT I Hereby Certify that AVAPECIA LIFE SCIENCES CORP., incorporation number BC1003976, and LIBERTY BIOPHARMA INC., incorporation number C1102183 were amalgamated as one company under the name LIBERTY BIOPHARMA INC. on Dece...
Microsoft Word - Notice of Change in Corporate Structure.docx NOTICE OF CHANGE IN CORPORATE STRUCTURE National Instrument 51-102 Section 4.9 This notice is provided pursuant to the requirements of Section 4.9 of National Instrument 51-102 Continuous Disclosure Obligations (NI 51-102). Item 1 Names of the parties to the transaction Avagenesis Corp...
Date: January 11, 2017 Jurisdictions: Alberta, British Columbia, Ontario
Form 51-102F3 Material Change Report (Avagenesis) FORM 51-102F3 Material Change Report 1. Name and Address of Company: Avagenesis Corp. 2270-8788 McKim Way Richmond, British Columbia V6X 4E2 2. Date of Material Change: January 3, 2017 3. News Release: The news release with respect to the material change was ...
Date: January 3, 2017 Jurisdictions: Alberta, British Columbia, Ontario
January 3, 2017 Avagenesis and Avapecia Complete Merger and Continue as Liberty Biopharma Inc. January 3, 2017 Richmond, British Columbia: Avagenesis Corp. (TSXV: VVA; Avagenesis) and Avapecia Life Sciences Corp. (CSE: VVS; Avapecia) (collectively referred to as the Companies) are pleased to announce the completion of the transactions contemplated in th...
Date: December 16, 2016 Jurisdictions: Alberta, British Columbia, Ontario
December 16, 2016 Avagenesis and Avapecia Announce Shareholder Approval of Amalgamation December 16, 2016, Vancouver, British Columbia Avagenesis Corp. (TSXV: VVA) (Avagenesis) and Avapecia Life Sciences Corp. (CSE: VVS) (Avapecia) are pleased to announce that the amalgamation of the companies previously announced on ...
Date: December 8, 2016 Jurisdictions: Alberta, British Columbia, Ontario
Microsoft Word - 20161207 VVA and VVS Bckgrd on Proposed Merger vfinal.docx Avagenesis and Avapecia Jointly Provide Additional Disclosure With Respect to the Amalgamation December 8, 2016 Calgary, Alberta and Richmond, British Columbia: Avagenesis Corp. (TSXV: VVA; Avagenesis) and Avapecia Life Sciences Corp. (CSE: VVS; Avapecia) (collectively referred to...
Date: December 1, 2016 Jurisdictions: Alberta, British Columbia, Ontario
December 1, 2016 Avagenesis Closes Private Placement December 1, 2016 - Calgary, Alberta: Avagenesis Corp. (TSXV: VVA) (Avagenesis or Company) announces that it has closed a non-brokered private placement consisting of the issuance of 400,000 common shares to 3 investors for gross proceeds of $100,000 at $0.25 per common share (Private Placement). ...
Date: November 21, 2016 Jurisdictions: Alberta, British Columbia, Ontario
post-IFRS 52-109FV2 [F] (CFO) (November 21, 2016) 1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Alan Tam, Chief Financial Officer of Avagenesis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Avagenesis Co...